Contact us to become a partner
NEWS - Larvol Launches AI-Powered Cancer Data Platform During ASCO 2020
The Larvol Group, a Software as a Service (SaaS) company with 125 employees, announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting. The Veri platform offers access to a knowledgebase for predictive biomarkers in oncology and is free for non-commercial use.
Read moreLARVOL OMNI - Next generation KOL tracking
Tracking KOLs ensures that your products are included in relevant discussions. Knowing where a KOL is going to be – which conferences, symposiums, and CME events they’ll be attending or presenting at – allows for crucial opportunities to engage with a KOL and the other physicians who follow them. Our customers explain how valuable it is to see that a KOL is publicly discussing mechanisms of action that they’re working with and creates an opportunity to reach out and establish a key relationship.
Learn more about KOL trackingPULSE HEATMAPS - Real-time market intelligence
A visual landscape of trial activity within your disease area(s) according to specific conditions, MOAs, biomarkers, and more. Results can be adjusted by date range, phase, activity and sponsor type. Heatmaps are linked directly to trial data and can be exported as a PDF or Excel.
Read more market intelligenceVERI- The ultimate biomarker platform
Scientific and medical experts who serve in an advisory capacity can bring highly relevant insights and expertise in partnership with life science organizations. Advisory positions come in a number of different guises: corporate advisory boards, whose members provide informed guidance on scientific, medical and business aspects, journal editorial boards whose members are highly qualified and recognized for their contributions to their field of work or medical society board or committee members who are on the forefront of medical, policy and advocacy issues.
Read more about biomarkers